| Literature DB >> 23246570 |
Christine Mölzer1, Barbara Pfleger, Elisabeth Putz, Antonia Roßmann, Ursula Schwarz, Marlies Wallner, Andrew C Bulmer, Karl-Heinz Wagner.
Abstract
Epidemiological studies report a negative association between circulating bilirubin concentrations and the risk for cancer and cardiovascular disease. Structurally related tetrapyrroles also possess in vitro anti-genotoxic activity and may prevent mutation prior to malignancy. Furthermore, few data suggest that tetrapyrroles exert anti-carcinogenic effects via induction of cell cycle arrest and apoptosis. To further investigate whether tetrapyrroles provoke DNA-damage in human cancer cells, they were tested in the single cell gel electrophoresis assay (SCGE). Eight tetrapyrroles (unconjugated bilirubin, bilirubin ditaurate, biliverdin, biliverdin-/bilirubin dimethyl ester, urobilin, stercobilin and protoporphyrin) were added to cultured Caco2 and HepG2 cells and their effects on comet formation (% tail DNA) were assessed. Flow cytometric assessment (apoptosis/necrosis, cell cycle, intracellular radical species generation) assisted in revealing underlying mechanisms of intracellular action. Cells were incubated with tetrapyrroles at concentrations of 0.5, 5 and 17μM for 24h. Addition of 300μM tertiary-butyl hydroperoxide to cells served as a positive control. Tetrapyrrole incubation mostly resulted in increased DNA-damage (comet formation) in Caco2 and HepG2 cells. Tetrapyrroles that are concentrated within the intestine, including protoporphyrin, urobilin and stercobilin, led to significant comet formation in both cell lines, implicating the compounds in inducing DNA-damage and apoptosis in cancer cells found within organs of the digestive system.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23246570 PMCID: PMC3569715 DOI: 10.1016/j.yexcr.2012.12.003
Source DB: PubMed Journal: Exp Cell Res ISSN: 0014-4827 Impact factor: 3.905
Fig. 2DNA-damaging effects of (A) protoporphyrin, (B) urobilin and (C) stercobilin in HepG2 cells. ⁎n: significantly different to negative control, ⁎p: significantly different to positive control, #n: not significantly different to negative control, however strong trend (p≤0.1).
Mean % tail DNA in Caco2 and HepG2 cells (± SD) after 24 h TP incubations, compared to positive and negative controls.
| BR 0.5 | 18.7±3p | 36.5±4 | 21.3±3 |
| BR 5 | 21.3±3.8p | ||
| BR 17 | 13.8±1.9np | ||
| BRDT 0.5 | 10.8±2.6np | 29.1±2.7 | 7.7±2.0 |
| BRDT 5 | 11.7±2.6p | ||
| BRDT 17 | 18.2±4.1p | ||
| BR-DME 0.5 | 8.7±2.7 | 21.9±3.9 | 9.9±4.0 |
| BR-DME 5 | 11.5±2.3p | ||
| BR-DME 17 | 15.0±6.9p | ||
| BV 0.5 | 20.9±4.3p | 30.1±5.0 | 16.5±2.6 |
| BV 5 | 20.8±2 | ||
| BV 17 | 18.4±2.7 | ||
| BV-DME 0.5 | 15.6±3.5p | 26.6±2.9 | 15.5±2.5 |
| BV-DME 5 | 15.3±3.2p | ||
| BV-DME 17 | 12.9±2.2p | ||
| BR 0.5 | 10.8±2.8 | 18.5±3.9 | 9.3±1.0 |
| BR 5 | 9.2±2.9 | ||
| BR 17 | 9.7±1.3 | ||
| BRDT 0.5 | 8.2±0.8p | 13.3±0.9 | 7.4±2.0 |
| BRDT 5 | 8.8±1.4p | ||
| BRDT 17 | 8.5±1.1p | ||
| BR-DME 0.5 | 8.8±2.5p | 13.4±2.5 | 6.8±2.3 |
| BR-DME 5 | 9.3±1.3p | ||
| BR-DME 17 | 8.7±2.5 | ||
| BV 0.5 | 17.2±1.4n | 16.8±0.7 | 12.3±1.0 |
| BV 5 | 15.1±0.9np | ||
| BV 17 | 16.6±1.3n | ||
| BV-DME 0.5 | 17.0±2.2np | 21.6±2.1 | 12.3±1.6 |
| BV-DME 5 | 14.6±2.0p | ||
| BV-DME 17 | 17.8±1.4np | ||
BR: unconjugated bilirubin, BRDT: bilirubin ditaurate, BV: biliverdin, BV-DME: biliverdin dimethyl ester, TP: tetrapyrrole.
p: significantly different to positive control (p≤0.05).
n: significantly different to negative control (p≤0.05).
np: significantly different to negative and positive controls (p≤0.05).
Correlations (r) of comet tail DNA percentages (% tail DNA) and flow cytometry parameters (cell death, ROS formation) in Caco2 and HepG2 cells.
| BR | BRDT | BR-DME | BV | BV-DME | SB | PRO | |
|---|---|---|---|---|---|---|---|
| Necrosis | −0.726 | ||||||
| Hydroperoxide | 0.727 | 0.904 | |||||
| BR | BRDT | BV-DME | UB | SB | PRO | ||
| Apoptosis | 0.644 p=0.010 | ||||||
| Superoxide | 0.547 | 0.583 | |||||
BR: unconjugated bilirubin, BRDT: bilirubin ditaurate, BR-DME: bilirubin dimethyl ester, BV: biliverdin, BV-DME: biliverdin dimethyl ester, UB: urobilin, SB: stercobilin, PRO: protoporphyrin.#non-significant trend.
Fig. 3Effects of 24 h PRO (A), UB (B) and SB (C) incubation in Caco2 cells, on cell cycle progression (PI-staining). PRO: protoporphyrin, UB: urobilin, SB: stercobilin; ⁎n: significantly different to negative control (p≤0.05), #n: tends to differ from negative control (p≤0.1).